Altered blood–brain barrier and blood–spinal cord barrier dynamics in amyotrophic lateral sclerosis: Impact on medication efficacy and safety
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Altered blood–brain barrier and blood–spinal cord barrier dynamics in amyotrophic lateral sclerosis: Impact on medication efficacy and safety
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-01-20
DOI
10.1111/bph.15802
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Transporters
- (2021) Stephen PH Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Expression and Cellular Distribution of P-Glycoprotein and Breast Cancer Resistance Protein in Amyotrophic Lateral Sclerosis Patients
- (2020) Erwin A van Vliet et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Symptomatic pharmacotherapy in ALS: data analysis from a platform-based medication management programme
- (2020) Thomas Meyer et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Comparison of Absolute Protein Abundances of Transporters and Receptors among Blood–Brain Barriers at Different Cerebral Regions and the Blood–Spinal Cord Barrier in Humans and Rats
- (2020) Yasuo Uchida et al. MOLECULAR PHARMACEUTICS
- L-Type amino acid transporter 1 as a target for drug delivery
- (2020) Elena Puris et al. PHARMACEUTICAL RESEARCH
- Physiological blood–brain transport is impaired with age by a shift in transcytosis
- (2020) Andrew C. Yang et al. NATURE
- Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
- (2020) Timothy Miller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global alterations to the choroid plexus blood-CSF barrier in amyotrophic lateral sclerosis
- (2020) J. Saul et al. Acta Neuropathologica Communications
- Blood–Brain Barrier Leakage Is Increased in Parkinson’s Disease
- (2020) Sarah Al-Bachari et al. Frontiers in Physiology
- Epidemiology of amyotrophic lateral sclerosis
- (2019) Elisa Longinetti et al. CURRENT OPINION IN NEUROLOGY
- Long‐term edaravone efficacy in amyotrophic lateral sclerosis: Post‐hoc analyses of Study 19 (MCI186‐19)
- (2019) Jeremy Shefner et al. MUSCLE & NERVE
- First-in-human trial of blood–brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound
- (2019) Agessandro Abrahao et al. Nature Communications
- Decoding the relationship between ageing and amyotrophic lateral sclerosis: a cellular perspective
- (2019) Virenkumar A Pandya et al. BRAIN
- Active poly‐GA vaccination prevents microglia activation and motor deficits in a C9orf72 mouse model
- (2019) Qihui Zhou et al. EMBO Molecular Medicine
- Antibody Therapy Targeting RAN Proteins Rescues C9 ALS/FTD Phenotypes in C9orf72 Mouse Model
- (2019) Lien Nguyen et al. NEURON
- ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?
- (2019) Rita Mejzini et al. Frontiers in Neuroscience
- Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics
- (2018) Yijun Pan et al. ADVANCED DRUG DELIVERY REVIEWS
- Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
- (2018) Melanie D. Sweeney et al. Nature Reviews Neurology
- Repeated Intrathecal Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis
- (2018) Ki-Wook Oh et al. ANNALS OF NEUROLOGY
- Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model
- (2017) Gary N.Y. Chan et al. NEUROSCIENCE LETTERS
- Ageing, neurodegeneration and brain rejuvenation
- (2016) Tony Wyss-Coray NATURE
- Supportive and symptomatic management of amyotrophic lateral sclerosis
- (2016) Esther V. Hobson et al. Nature Reviews Neurology
- C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD
- (2016) Yuanjing Liu et al. NEURON
- Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs
- (2016) Jie Jiang et al. NEURON
- From animal models to human disease: a genetic approach for personalized medicine in ALS
- (2016) Vincent Picher-Martel et al. Acta Neuropathologica Communications
- Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice
- (2015) Owen M. Peters et al. NEURON
- C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD
- (2015) Jacqueline G. O’Rourke et al. NEURON
- Alterations of the blood-spinal cord barrier in sporadic amyotrophic lateral sclerosis
- (2015) Shoichi Sasaki NEUROPATHOLOGY
- Alterations in the blood–spinal cord barrier in TDP-43 conditional knockout mice
- (2015) Shoichi Sasaki et al. NEUROSCIENCE LETTERS
- Microvascular disturbance with decreased pericyte coverage is prominent in the ventral horn of patients with amyotrophic lateral sclerosis
- (2015) Misaki Yamadera et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Developments in treatments for amyotrophic lateral sclerosis via intracerebroventricular or intrathecal delivery
- (2014) Philip Van Damme et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Inhibiting drug efflux transporters improves efficacy of ALS therapeutics
- (2014) Michael R. Jablonski et al. Annals of Clinical and Translational Neurology
- Loss of TDP-43 causes age-dependent progressive motor neuron degeneration
- (2013) Yohei Iguchi et al. BRAIN
- Fused in Sarcoma (FUS) Protein Lacking Nuclear Localization Signal (NLS) and Major RNA Binding Motifs Triggers Proteinopathy and Severe Motor Phenotype in Transgenic Mice
- (2013) Tatyana A. Shelkovnikova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Altered Brain Uptake of Therapeutics in a Triple Transgenic Mouse Model of Alzheimer’s Disease
- (2013) Dharmini C. Mehta et al. PHARMACEUTICAL RESEARCH
- Blood–spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis
- (2012) Ethan A. Winkler et al. ACTA NEUROPATHOLOGICA
- Impaired blood–brain/spinal cord barrier in ALS patients
- (2012) Svitlana Garbuzova-Davis et al. BRAIN RESEARCH
- Blood–Spinal Cord Barrier Pericyte Reductions Contribute to Increased Capillary Permeability
- (2012) Ethan A Winkler et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Selective increase of two ABC drug efflux transporters at the blood–spinal cord barrier suggests induced pharmacoresistance in ALS
- (2012) Michael R. Jablonski et al. NEUROBIOLOGY OF DISEASE
- Blood–brain barrier P-glycoprotein function in Alzheimer's disease
- (2011) Daniëlle M. E. van Assema et al. BRAIN
- Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis
- (2011) Kazunori Miyazaki et al. JOURNAL OF NEUROSCIENCE RESEARCH
- P-glycoprotein expression and function are increased in an animal model of amyotrophic lateral sclerosis
- (2010) Aline Milane et al. NEUROSCIENCE LETTERS
- Prognostic factors in ALS: A critical review
- (2009) Adriano Chiò et al. Amyotrophic Lateral Sclerosis
- In VivoMorphological Changes in Animal Models of Amyotrophic Lateral Sclerosis and Alzheimer's-Like Disease: MRI Approach
- (2009) Pavle R. Andjus et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
- Impaired blood–brain and blood–spinal cord barriers in mutant SOD1-linked ALS rat
- (2009) Charles Nicaise et al. BRAIN RESEARCH
- Structure and function of the blood–brain barrier
- (2009) N. Joan Abbott et al. NEUROBIOLOGY OF DISEASE
- DECREASED mRNA EXPRESSION OF TIGHT JUNCTION PROTEINS IN LUMBAR SPINAL CORDS OF PATIENTS WITH ALS
- (2009) J. S. Henkel et al. NEUROLOGY
- TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration
- (2009) I. Wegorzewska et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular dissection of ALS-associated toxicity of SOD1 in transgenic mice using an exon-fusion approach
- (2008) Deng Han-Xiang et al. HUMAN MOLECULAR GENETICS
- Decreased blood–brain barrier P-glycoprotein function in the progression of Parkinson’s disease, PSP and MSA
- (2008) A. L. Bartels et al. JOURNAL OF NEURAL TRANSMISSION
- ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration
- (2008) Zhihui Zhong et al. NATURE NEUROSCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now